Todd Dorfman1*, Amber Krogsrud2 and Alison Gracom3
This case study examines the efficacy of a proprietary Directline™ delivery method via a lozenge compared to a gummy supplement. The Directline™ delivery enabled three times more ingredients to be delivered and extended the benefits in the body by 33% compared to the gummy, resulting in higher bioavailability through the lozenge.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 